These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12699060)

  • 1. Negative CEA values in metastatic colorectal carcinoma and the likelihood of complete chemotherapy response.
    Tomasevic Z; Jelic S; Nikolic L; Filipovic I; Stamatovic L; Radosavljevic D
    Int J Biol Markers; 2003; 18(1):28-32. PubMed ID: 12699060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Discordance between Carcinoembryonic Antigen Levels and RECIST in Metastatic Colorectal Cancer.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Oh ST; Kim JG; Choi MH; Lee MA
    Cancer Res Treat; 2018 Jan; 50(1):283-292. PubMed ID: 28494536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients With Elevated CEA.
    Gulhati P; Yin J; Pederson L; Schmoll HJ; Hoff P; Douillard JY; Hecht JR; Tournigand C; Tebbut N; Chibaudel B; Gramont A; Shi Q; Overman MJ
    J Natl Cancer Inst; 2020 Nov; 112(11):1127-1136. PubMed ID: 32191317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer.
    Spindler KL; Christensen IJ; Nielsen HJ; Jakobsen A; Brünner N
    Tumour Biol; 2015 Jun; 36(6):4301-8. PubMed ID: 25608838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary carcinoembryonic antigen levels in diagnosis of occult hepatic metastases from colorectal carcinoma.
    Waisberg J; Palma RT; Neto LC; Martins LC; Oliveira MS; Nagashima CA; Godoy AC; Goffi FS
    World J Gastroenterol; 2003 Jul; 9(7):1589-93. PubMed ID: 12854170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?
    Selcukbiricik F; Bilici A; Tural D; Erdamar S; Soyluk O; Buyukunal E; Demirelli F; Serdengecti S
    Tumour Biol; 2013 Aug; 34(4):2233-9. PubMed ID: 23625655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
    Moretto R; Rossini D; Conca V; Lonardi S; Rasola C; Antoniotti C; Santini D; Marmorino F; Tomasello G; Borelli B; Caponnetto S; Zucchelli G; Zaniboni A; Ambrosini M; Buonadonna A; Fanchini L; Cupini S; Masi G; Falcone A; Cremolini C
    Br J Cancer; 2021 Sep; 125(6):839-845. PubMed ID: 34253871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer.
    Quidde J; Denne L; Kutscheidt A; Kindler M; Kirsch A; Kripp M; Petersen V; Schulze M; Seraphin J; Tummes D; Arnold D; Stein A
    Oncol Res Treat; 2017; 40(1-2):21-26. PubMed ID: 28192780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Lee MA
    Asia Pac J Clin Oncol; 2018 Jun; 14(3):239-246. PubMed ID: 29044941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer.
    Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Fan FS; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
    Int J Colorectal Dis; 2001 Apr; 16(2):96-101. PubMed ID: 11355325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).
    Holch JW; Ricard I; Stintzing S; Fischer von Weikersthal L; Decker T; Kiani A; Vehling-Kaiser U; Heintges T; Kahl C; Kullmann F; Scheithauer W; Moehler M; Jelas I; Modest DP; Westphalen CB; von Einem JC; Michl M; Heinemann V
    Eur J Cancer; 2019 Jan; 106():115-125. PubMed ID: 30496943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of carcinoembryonic antigen for monitoring tumor progression during palliative chemotherapy in metastatic colorectal cancer.
    Kim G; Jung EJ; Ryu CG; Hwang DY
    Yonsei Med J; 2013 Jan; 54(1):116-22. PubMed ID: 23225807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
    Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
    Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab.
    Petrioli R; Licchetta A; Roviello G; Pascucci A; Francini E; Bargagli G; Conca R; Miano ST; Marzocca G; Francini G;
    Cancer Invest; 2012 Jan; 30(1):65-71. PubMed ID: 22236191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for the early detection of relapses in metastatic colorectal cancers.
    Chereches G; Barbos O; Buiga R; Balacescu O; Iancu D; Todor N; Balacescu L; Miron N; Bejinariu N; Ciuleanu TE
    J BUON; 2017; 22(3):658-666. PubMed ID: 28730771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating carcinoembryonic antigen in pancreatic carcinoma.
    Kalser MH; Barkin JS; Redlhammer D; Heal A
    Cancer; 1978 Sep; 42(3 Suppl):1468-71. PubMed ID: 709516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum carcinoembryonic antigen pre-operative level in colorectal cancer: revisiting risk stratification.
    Iacuzzo C; Germani P; Troian M; Cipolat Mis T; Giudici F; Osenda E; Bortul M; de Manzini N
    ANZ J Surg; 2021 Jun; 91(6):E367-E374. PubMed ID: 33870621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.